Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group.
| dc.contributor.author | Saip, P. | |
| dc.contributor.author | Icli, F. | |
| dc.contributor.author | Altundag, K. | |
| dc.contributor.author | Coskun, U. | |
| dc.contributor.author | Paydas, S. | |
| dc.contributor.author | Basaran, G. | |
| dc.contributor.author | Dogu, G. G. | |
| dc.contributor.author | Eralp, Y. | |
| dc.contributor.author | Uslu, R. | |
| dc.contributor.author | Sevinc, A. | |
| dc.contributor.author | Onur, H. | |
| dc.contributor.author | Mandel, N. M. | |
| dc.contributor.author | Sezgin, C. | |
| dc.contributor.author | Altinbas, M. | |
| dc.contributor.author | Guler, N. | |
| dc.contributor.author | Isikdogan, A. | |
| dc.contributor.author | Gokmen, E. | |
| dc.contributor.author | Uygun, K. | |
| dc.contributor.author | Ustuner, Z. | |
| dc.contributor.author | Yaren, A. | |
| dc.date.accessioned | 2021-03-06T12:05:41Z | |
| dc.date.available | 2021-03-06T12:05:41Z | |
| dc.date.issued | 2011 | |
| dc.identifier.citation | Icli F., Altundag K., Coskun U., Paydas S., Basaran G., Saip P., Dogu G. G. , Eralp Y., Uslu R., Sevinc A., et al., "Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group.", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_f23ad3b5-fdc6-4f62-b02b-55b2a56f47a1 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/158890 | |
| dc.identifier.uri | https://doi.org/10.1200/jco.2011.29.15_suppl.629 | |
| dc.language.iso | eng | |
| dc.subject | Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.title | Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group. | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 29 | |
| dc.identifier.issue | 15 | |
| dc.contributor.firstauthorID | 200502 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Makale [92796]